No Data
US Stock MarketDetailed Quotes
OPK Opko Health
Watchlist
1.460
-0.070-4.58% Close 11/30 16:00 ET
1.490+0.030+2.05%
Post 16:37 ET
1.550High1.455Low4.08MVolume
1.520Open1.530Pre Close6.02MTurnover0.98%Turnover RatioLossP/E (TTM)1.13BMarket Cap2.24052wk HighLossP/E (Static)773.06MShares1.00052wk Low0.78P/B609.19MFloat Cap19.200Historical High--Dividend TTM417.26MShs Float0.210Historical Low--Div YieldTTM6.21%Amplitude1.473Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Opko Health Company
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
Revenue Breakdown
Business
Currency:USD
2022/12/31
Stock NameRevenueRatio
Diagnostics755.63M75.25%
Pharmaceutical248.57M24.75%
News
Express News | BioReference Health And Prognos Health Collaborate To Advance Precision Medicine And Testing
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
BioReference Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a...
OPKO Health Insiders Placed Bullish Bets Worth US$5.10m
Over the last year, a good number of insiders have significantly increased their holdings in OPKO Health, Inc. (NASDAQ:OPK). This is encouraging because it indicates that insiders are more optimistic
Comments
The substantial insider purchases and high insider ownership at OPKO Health imply a positive outlook, despite the company's reported loss last year.
OPKO Health Insiders Placed Bullish Bets Worth US$5.10mInvestors could stand to gain if OPKO Health turns profitable quickly. Despite recent underperformance against a market that grew by 9.0% last year, it may still present unresolved issues. Recommendations urge investors to invest in a high-quality business.
$Opko Health(OPK.US$ going back down. guaranteed.
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--